PMID- 4075635
OWN - NLM
STAT- MEDLINE
DCOM- 19860207
LR  - 20190829
IS  - 0009-9201 (Print)
IS  - 0009-9201 (Linking)
VI  - 28
IP  - 4
DP  - 1985 Dec
TI  - Recent immunologic advances affecting the management of ovarian cancer.
PG  - 853-71
FAU - Freedman, R S
AU  - Freedman RS
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Clin Obstet Gynecol
JT  - Clinical obstetrics and gynecology
JID - 0070014
RN  - 0 (Adjuvants, Immunologic)
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antigens, Neoplasm)
SB  - IM
MH  - Adjuvants, Immunologic/therapeutic use
MH  - Antibodies, Monoclonal/therapeutic use
MH  - Antigens, Neoplasm/analysis
MH  - Combined Modality Therapy
MH  - Cytotoxicity, Immunologic
MH  - Female
MH  - Humans
MH  - Immunity, Cellular
MH  - Immunotherapy/*methods
MH  - Ovarian Neoplasms/immunology/*therapy
EDAT- 1985/12/01 00:00
MHDA- 1985/12/01 00:01
CRDT- 1985/12/01 00:00
PHST- 1985/12/01 00:00 [pubmed]
PHST- 1985/12/01 00:01 [medline]
PHST- 1985/12/01 00:00 [entrez]
AID - 10.1097/00003081-198528040-00020 [doi]
PST - ppublish
SO  - Clin Obstet Gynecol. 1985 Dec;28(4):853-71. doi: 
      10.1097/00003081-198528040-00020.